Cargando…
Integrated MicroRNA–mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer
MicroRNAs (miRNAs) simultaneously modulate different oncogenic networks, establishing a dynamic system of gene expression and pathway regulation. In this study, we analyzed global miRNA and messenger RNA (mRNA) expression profiles of 17 cell lines representing different molecular breast cancer subty...
Autores principales: | Bottai, Giulia, Diao, Lixia, Baggerly, Keith A., Paladini, Laura, Győrffy, Balázs, Raschioni, Carlotta, Pusztai, Lajos, Calin, George A., Santarpia, Libero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297825/ https://www.ncbi.nlm.nih.gov/pubmed/28106823 http://dx.doi.org/10.3390/ijms18010194 |
Ejemplares similares
-
Targeting microRNAs as key modulators of tumor immune response
por: Paladini, Laura, et al.
Publicado: (2016) -
Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Munkácsy, Gyöngyi, et al.
Publicado: (2023) -
An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes
por: Győrffy, Balázs, et al.
Publicado: (2018) -
AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients
por: Bottai, Giulia, et al.
Publicado: (2016) -
An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers
por: Bottai, Giulia, et al.
Publicado: (2016)